Duodenal Mucosal Resurfacing System (DMR) for T2Di Study - Medical / Health Care - Medical Research
The REVITA-T2Di Study will look at a potential procedure called duodenal mucosal resurfacing (DMR). The DMR procedure acts on the innermost layer (mucosa) of the duodenum (the part of the small intestine located immediately after the stomach). By removing an excess layer, the treatment may improve blood sugar control. This treatment may eliminate or reduce the need for insulin injections in the future.
Details
The REVITA-T2Di Study will consist of three periods:
Screening Period (up to 3 months)
This will consist of 3 or 4 study visits at the study center or your home. It is during this period that it is determined if the study is suitable for you. The study doctor may adjust medications during this period.
Day of Procedure (1 Day)
You will visit the study center to have the procedure.
Follow-Up Period (about 11 months)
This will consist of 6 study visits at the study center or your home. You will also receive 5 phone calls. It is during this period that your progress will be monitored. The study doctor will remove insulin and further adjust your medications during this period.
